maxsattana-istockphoto-com-plant-
maxsattana / iStockphoto.com
4 April 2017BiotechJane Wainwright

Plants, patents and political challenges

Followers of the changing life sciences patenting landscape will be well aware of the extended saga at the European Patent Office (EPO) regarding two cases heard together and known as Broccoli and Tomatoes. In these cases the Enlarged Board of Appeal of the EPO decided that, while essentially biological processes of producing plants or animals (such as crossing of plants or sexual reproduction of animals) are excluded from patentability, new products derived from such processes are not excluded from patentability simply because they resulted from such an essentially biological process.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotech
3 September 2026   Turnaround for 10x after Federal Circuit setback as Delaware jury finds Qiagen-owned Parse infringed three patents covering single-cell sequencing technology.
Biotech
1 September 2026   Judges dismissed an appeal from MSN Laboratories, which was hoping to show that several patents covering Cabometyx were invalid and would not be infringed by its generic product.
Biotech
31 August 2026   Efforts to shut down an eight-patent dispute over cancer-detection technology have run into a hurdle in a Delaware federal court.